AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 28187400 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion plus escitalopram combination (bupropion-SSRI combination)
Number of subjects: 106
Study 28187400 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP threshold based assignment
Number of subjects: 106
Study 28187400 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall population
Number of subjects: 106
Study 28187400 — intervention group
Group type: EXPERIMENTAL
Intervention: Side effect burden
Number of subjects: 106
Study 25274460 — intervention group
Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 60
Study 25274460 — intervention group
Group type: EXPERIMENTAL
Intervention: Brisk Walking
Number of subjects: 60
Study 25274460 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 60
Study 22527138 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfacalcidol + 500 mg calcium (group A)
Number of subjects: 214
Study 22527138 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D + 1000 mg calcium (group B)
Number of subjects: 214
Study 22073889 — intervention group
Group type: EXPERIMENTAL
Intervention: GA + 2 Hz‐EA
Number of subjects: 48
Study 22073889 — intervention group
Group type: EXPERIMENTAL
Intervention: GA + 100 Hz‐EA
Number of subjects: 48
Study 22073889 — intervention group
Group type: EXPERIMENTAL
Intervention: GA + 2 Hz/100 Hz‐EA
Number of subjects: 48
Study 22073889 — intervention group
Group type: COMPARATOR
Intervention: RGA
Number of subjects: 48
Study 19222323 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment over 17 weeks
Number of subjects: 99
Study 17034444 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized response technique (RRT)
Number of subjects: 500
Study 17034444 — intervention group
Group type: COMPARATOR
Intervention: Direct interview techniques and voluntary questionnaires
Number of subjects: 500
Study 14648310 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-lumen totally implantable subcutaneous port system (PORT)
Number of subjects: 43
Study 14648310 — intervention group
Group type: COMPARATOR
Intervention: Double-lumen central venous catheter (CVC)
Number of subjects: 43
Study 11238504 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin (1.0 microg/kg i.v. at 0 min)
Number of subjects: 7
Study 11238504 — intervention group
Group type: EXPERIMENTAL
Intervention: GHRH (1.0 microg/kg i.v. at 0 min)
Number of subjects: 7
Study 11238504 — intervention group
Group type: EXPERIMENTAL
Intervention: Hexarelin (HEX) (1.0 microg/kg i.v. at 0 min)
Number of subjects: 7
Study 11238504 — intervention group
Group type: EXPERIMENTAL
Intervention: Ghrelin + GHRH
Number of subjects: 7
Study 11238504 — intervention group
Group type: COMPARATOR
Intervention: Placebo (2 mL isotonic saline i.v. at 0 min)
Number of subjects: 7
Study 9669256 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (10 mg/min)
Number of subjects: 66
Study 9669256 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 66
Study 8310993 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene (30 mg)
Number of subjects: 3
Study 8310993 — intervention group
Group type: EXPERIMENTAL
Intervention: Ascorbic acid (300 mg)
Number of subjects: 3
Study 8310993 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study 3047335 — intervention group
Group type: EXPERIMENTAL
Intervention: Vincristine, cyclophosphamide, and doxorubicin (VCA) for six monthly cycles
Number of subjects: 229
Study 3047335 — intervention group
Group type: COMPARATOR
Intervention: No further therapy (Control group)
Number of subjects: 229
Study 29901736 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS-LNS (Lipid-Based Nutrient Supplements for women and children)
Number of subjects: 4011
Study 29901736 — intervention group
Group type: EXPERIMENTAL
Intervention: IFA-LNS (Iron and Folic Acid for women and LNS for children)
Number of subjects: 4011
Study 29901736 — intervention group
Group type: EXPERIMENTAL
Intervention: LNS-LNS
Number of subjects: 4011
Study 29901736 — intervention group
Group type: EXPERIMENTAL
Intervention: IFA-LNS
Number of subjects: 4011
Study 29901736 — intervention group
Group type: EXPERIMENTAL
Intervention: IFA-MNP
Number of subjects: 4011
Study 29901736 — intervention group
Group type: COMPARATOR
Intervention: IFA-Control
Number of subjects: 4011
Study 27509141 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot massage for 20 minutes after surgery
Number of subjects: 70
Study 27509141 — intervention group
Group type: COMPARATOR
Intervention: Control group (no foot massage)
Number of subjects: 70
Study 25904634 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic criteria for a septate uterus (DC group)
Number of subjects: 191
Study 25904634 — intervention group
Group type: COMPARATOR
Intervention: No diagnostic criteria (no DC group)
Number of subjects: 191
Study 24385639 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasoning training
Number of subjects: 699
Study 24385639 — intervention group
Group type: EXPERIMENTAL
Intervention: First annual booster
Number of subjects: 699
Study 24385639 — intervention group
Group type: EXPERIMENTAL
Intervention: Training adherence
Number of subjects: 699
Study 24385639 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher education, MMSE, better health, younger age
Number of subjects: 699
Study 24385639 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher MMSE
Number of subjects: 699
Study 24385639 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial training gain
Number of subjects: 699
Study 20925074 — intervention group
Group type: EXPERIMENTAL
Intervention: Orally dissolving carbidopa/levodopa (OD C/L)
Number of subjects: 20
Study 20925074 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral carbidopa/levodopa
Number of subjects: 20
Study 18202351 — intervention group
Group type: EXPERIMENTAL
Intervention: VF plus exercise
Number of subjects: 64
Study 18202351 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 64
Study 18202351 — intervention group
Group type: COMPARATOR
Intervention: VF alone
Number of subjects: 64
Study 16723047 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear plastic 'Anaesthetic Facemask'
Number of subjects: 60
Study 16723047 — intervention group
Group type: EXPERIMENTAL
Intervention: Clear plastic 'Air Cushion Mask'
Number of subjects: 60
Study 16723047 — intervention group
Group type: EXPERIMENTAL
Intervention: Black antistatic reusable rubber facemask
Number of subjects: 60
Study 14568963 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 lipid emulsion
Number of subjects: 12
Study 14568963 — intervention group
Group type: COMPARATOR
Intervention: Omega-6 lipid emulsion
Number of subjects: 12
Study 11738543 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 16
Study 11738543 — intervention group
Group type: EXPERIMENTAL
Intervention: Desipramine
Number of subjects: 16
Study 11738543 — intervention group
Group type: EXPERIMENTAL
Intervention: Both sertraline and desipramine (responders)
Number of subjects: 16
Study 11738543 — intervention group
Group type: EXPERIMENTAL
Intervention: Both sertraline and desipramine (non-responders)
Number of subjects: 16
Study 11738543 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical change (not medication)
Number of subjects: 16
Study 9455594 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonathon recruitment strategy
Number of subjects: 120
Study 9455594 — intervention group
Group type: EXPERIMENTAL
Intervention: Printed media recruitment strategy
Number of subjects: 120
Study 9455594 — intervention group
Group type: EXPERIMENTAL
Intervention: Word-of-mouth recruitment strategy
Number of subjects: 120
Study 9455594 — intervention group
Group type: EXPERIMENTAL
Intervention: Remaining recruitment approaches
Number of subjects: 120
Study 7930728 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonized children (n=49)
Number of subjects: 157
Study 7930728 — intervention group
Group type: COMPARATOR
Intervention: Noncolonized children (n=108)
Number of subjects: 157
Study 7930728 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequency of colonization
Number of subjects: 157
Study 3283426 — intervention group
Group type: EXPERIMENTAL
Intervention: Eledoisin
Number of subjects: 0
Study 3283426 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears
Number of subjects: 0
Study 31756189 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% neem seed oil in coconut oil (NC)
Number of subjects: 96
Study 31756189 — intervention group
Group type: COMPARATOR
Intervention: 0.05% potassium permanganate (KMnO4) foot bath
Number of subjects: 96
Study 28089184 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone wax (2.5 g applied onto uncovered bone)
Number of subjects: 100
Study 28089184 — intervention group
Group type: COMPARATOR
Intervention: Control (electrocautery only)
Number of subjects: 100
Study 26177518 — intervention group
Group type: EXPERIMENTAL
Intervention: IdeS (intravenous single ascending doses)
Number of subjects: 20
Study 26177518 — intervention group
Group type: EXPERIMENTAL
Intervention: IdeS (0.24 mg/kg)
Number of subjects: 20
Study 26177518 — intervention group
Group type: EXPERIMENTAL
Intervention: IdeS
Number of subjects: 20
Study 23261172 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (40 mg/day) and a regular sodium diet (194 ± 49 mmol Na+/day)
Number of subjects: 39
Study 23261172 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril plus valsartan (320 mg/day) and a low sodium diet (102 ± 52 mmol Na+/day)
Number of subjects: 39
Study 23261172 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal treatment
Number of subjects: 39
Study 23261172 — intervention group
Group type: EXPERIMENTAL
Intervention: PCSK9 at baseline
Number of subjects: 39
Study 20958105 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted breastfeeding support in the hospital and via telephone
Number of subjects: 74
Study 20958105 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual or electric breast pump used for 10-14 days
Number of subjects: 74
Study 20958105 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 74
Study 20958105 — intervention group
Group type: COMPARATOR
Intervention: No pump
Number of subjects: 74
Study 19323664 — intervention group
Group type: EXPERIMENTAL
Intervention: Ebastine 20 mg
Number of subjects: 7
Study 17582922 — intervention group
Group type: EXPERIMENTAL
Intervention: Zonisamide plus previous treatment
Number of subjects: 351
Study 17582922 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus previous treatment
Number of subjects: 351
Study 15044114 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid supplementation (400 microg/day)
Number of subjects: 300
Study 15044114 — intervention group
Group type: EXPERIMENTAL
Intervention: MTHFR genotypes (CC or CT)
Number of subjects: 300
Study 15044114 — intervention group
Group type: COMPARATOR
Intervention: MTHFR genotype TT
Number of subjects: 300
Study 15044114 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean folate intake
Number of subjects: 300
Study 11569889 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolasetron 100 mg daily
Number of subjects: 62
Study 11569889 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy (ondansetron or granisetron)
Number of subjects: 62
Study 9814477 — intervention group
Group type: EXPERIMENTAL
Intervention: R‐FSH (150 U)
Number of subjects: 9
Study 9814477 — intervention group
Group type: COMPARATOR
Intervention: SB (steroid and LH free) after R‐FSH administration
Number of subjects: 9
Study 8597984 — intervention group
Group type: EXPERIMENTAL
Intervention: Bactrim (sulphamethoxazole and trimethoprim)
Number of subjects: 8
Study 8597984 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 2527536 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril
Number of subjects: 12
Study 2527536 — intervention group
Group type: COMPARATOR
Intervention: Frusemide
Number of subjects: 12
Study 934535 — intervention group
Group type: EXPERIMENTAL
Intervention: Reserpine (1.5 mg/1.7 m2 surface) administered as a single i.m. injection
Number of subjects: 30
Study 934535 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged reserpine medication (0.2 mg reserpine 3 times a week for 6 weeks)
Number of subjects: 30
Study 934535 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged reserpine medication
Number of subjects: 30
Study 30767748 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting during Ramadhan
Number of subjects: 0
Study 30767748 — intervention group
Group type: EXPERIMENTAL
Intervention: Dehydration
Number of subjects: 0
Study 30767748 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized trial
Number of subjects: 0
Study 31377704 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone communication of benign biopsy results
Number of subjects: 0
Study 31377704 — intervention group
Group type: COMPARATOR
Intervention: In-person communication of benign biopsy results
Number of subjects: 0
Study 28525788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for stimulant abuse/dependence
Number of subjects: 270
Study 26105529 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric exercise (ECC2) on the ipsilateral leg
Number of subjects: 26
Study 26105529 — intervention group
Group type: COMPARATOR
Intervention: Eccentric exercise (ECC2) on the contralateral leg
Number of subjects: 26
Study 22878222 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise programme
Number of subjects: 70
Study 20935256 — intervention group
Group type: EXPERIMENTAL
Intervention: Pathogen inactivated platelet components (PC‐Test)
Number of subjects: 645
Study 20935256 — intervention group
Group type: COMPARATOR
Intervention: Conventional platelet components (Reference)
Number of subjects: 645
Study 19646495 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure condition (chocolate craving manipulated)
Number of subjects: 68
Study 19646495 — intervention group
Group type: COMPARATOR
Intervention: Non-exposure condition
Number of subjects: 68
Study 17294169 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day course of antibiotics and catheter replacement 4 hours after first antibiotic administration
Number of subjects: 60
Study 17294169 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (no antibiotics, no catheter replacement)
Number of subjects: 60
Study 17294169 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-day course of antibiotics and catheter replacement
Number of subjects: 60
Study 17294169 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 60
Study 15153170 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat (3 x 120 mg/day)
Number of subjects: 384
Study 15153170 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 384
Study 11869760 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 0
Study 11869760 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 0
Study 9502305 — intervention group
Group type: EXPERIMENTAL
Intervention: Donjoy Legend brace
Number of subjects: 11
Study 9502305 — intervention group
Group type: EXPERIMENTAL
Intervention: Bledsoe Brace Force III
Number of subjects: 11
Study 9502305 — intervention group
Group type: COMPARATOR
Intervention: Placebo brace
Number of subjects: 11
Study 9120652 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed educational course on movement disorders
Number of subjects: 492
Study 9120652 — intervention group
Group type: COMPARATOR
Intervention: Control group (did not receive the mailed CME course)
Number of subjects: 492
Study 2048868 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin, 500 mg orally every 12 hours
Number of subjects: 801
Study 2048868 — intervention group
Group type: COMPARATOR
Intervention: Norfloxacin, 400 mg orally every 12 hours
Number of subjects: 801
Study 7236928 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontalis EMG-biofeedback
Number of subjects: 40
Study 7236928 — intervention group
Group type: COMPARATOR
Intervention: High expectations of cure (Control)
Number of subjects: 40
Study 31094774 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg amisulpride
Number of subjects: 560
Study 31094774 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg amisulpride
Number of subjects: 560
Study 31094774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 560
Study 26547487 — intervention group
Group type: EXPERIMENTAL
Intervention: HyFoSy with ExEm foam
Number of subjects: 40
Study 26547487 — intervention group
Group type: COMPARATOR
Intervention: HyCoSy with saline medium
Number of subjects: 40
Study 25440791 — intervention group
Group type: EXPERIMENTAL
Intervention: Interdisciplinary palliative care intervention
Number of subjects: 200
Study 23152584 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunohistochemical assay of sarcolemmal chloride channel abundance using 2 different ClC1‐specific antibodies
Number of subjects: 0
Study 20551460 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine 2.0-2.5 mg/kg/day
Number of subjects: 78
Study 20551460 — intervention group
Group type: COMPARATOR
Intervention: Mesalazine 4 g/day
Number of subjects: 78
Study 18614347 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate/salmeterol 250/50
Number of subjects: 782
Study 18614347 — intervention group
Group type: COMPARATOR
Intervention: Salmeterol 50 microg
Number of subjects: 782
Study 16371154 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (400 mg single dose in second trimester)
Number of subjects: 0
Study 16371154 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 0
Study 12460041 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive resisted isotonic quadriceps and hamstrings exercise and training on a cycle ergometer three times weekly for 12 weeks
Number of subjects: 0
Study 12460041 — intervention group
Group type: COMPARATOR
Intervention: Nonprogressive program of range-of-motion exercises
Number of subjects: 0
Study 10597763 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg of phytonadione IV
Number of subjects: 22
Study 10597763 — intervention group
Group type: COMPARATOR
Intervention: 1 mg of phytonadione SC
Number of subjects: 22
Study 8751690 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored scan delay (group 2, n = 22)
Number of subjects: 48
Study 8751690 — intervention group
Group type: COMPARATOR
Intervention: Standard scan delay of 20 or 22 sec (group 1, n = 26)
Number of subjects: 48
Study 1423955 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem (20 mg followed by 25 mg bolus doses and 10 and 15 mg/hr infusion for 24 hours)
Number of subjects: 32
Study 1423955 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous diltiazem
Number of subjects: 32
Study 3869435 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (6 micrograms/kg)
Number of subjects: 0
Study 3869435 — intervention group
Group type: COMPARATOR
Intervention: Diltiazem (500 micrograms/kg)
Number of subjects: 0
Study 31444189 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle treatment (information emphasising the disease's lifestyle causes)
Number of subjects: 738
Study 29768319 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress echocardiography
Number of subjects: 240
Study 29768319 — intervention group
Group type: COMPARATOR
Intervention: Stress myocardial perfusion imaging (MPI)
Number of subjects: 240
Study 26550945 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilute vasopressin
Number of subjects: 60
Study 26550945 — intervention group
Group type: COMPARATOR
Intervention: Dilute epinephrine
Number of subjects: 60
Study 24499772 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole Foods, plant-based, macrobiotic-style (n=22)
Number of subjects: 71
Study 24499772 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Fat with 10 g of ground flaxseed added daily (n=49)
Number of subjects: 71
Study 24499772 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Fat without 10 g of ground flaxseed added daily (n=49)
Number of subjects: 71
Study 24499772 — intervention group
Group type: COMPARATOR
Intervention: Moderate Fat group
Number of subjects: 71
Study 20854868 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation (tDCS) applied over the dorsolateral prefrontal cortex using a 2 mA-current for 20 min, twice-daily, for 5 consecutive days.
Number of subjects: 31
Study 20155617 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of carotenoids and myo‐inositol
Number of subjects: 0
Study 17524594 — intervention group
Group type: EXPERIMENTAL
Intervention: High marking of the argumentative orientation and daily estimates
Number of subjects: 0
Study 17524594 — intervention group
Group type: COMPARATOR
Intervention: Low marking of the argumentative orientation and yearly estimates
Number of subjects: 0
Study 15212190 — intervention group
Group type: EXPERIMENTAL
Intervention: Tulobuterol TTS (Hokunalin Tape)
Number of subjects: 24
Study 15212190 — intervention group
Group type: EXPERIMENTAL
Intervention: Tulobuterol TTS (Hokunalin Tape) with inhalational steroids
Number of subjects: 24
Study 15212190 — intervention group
Group type: EXPERIMENTAL
Intervention: Tulobuterol TTS (Hokunalin Tape) without inhalational steroids
Number of subjects: 24
Study 15212190 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhalational steroids
Number of subjects: 24
Study 11769150 — intervention group
Group type: EXPERIMENTAL
Intervention: FPD patch
Number of subjects: 22
Study 11769150 — intervention group
Group type: COMPARATOR
Intervention: Direct suturing
Number of subjects: 22
Study 8398291 — intervention group
Group type: EXPERIMENTAL
Intervention: Granisetron 3 mg
Number of subjects: 166
Study 8398291 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron 5 mg
Number of subjects: 166
Study 8398291 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron 8 mg
Number of subjects: 166
Study 2427411 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentosan polysulphate (SP54) intravenously and subsequently orally
Number of subjects: 55
Study 2427411 — intervention group
Group type: COMPARATOR
Intervention: Control group received the infusion solution and vasodilator drugs
Number of subjects: 55
Study 30766594 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 µg oral clonidine pre‐medication
Number of subjects: 108
Study 30766594 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 µg oral clonidine pre‐medication
Number of subjects: 108
Study 30766594 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oral clonidine pre‐medication)
Number of subjects: 108
Study 27031473 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (50,000 IU/week)
Number of subjects: 18